A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability...

Original article published by Newsweek: Available at https://www.newsweek.com/why-are-some-global-health-efforts-failing-opinion-1751649 HARALD NUSSERHEAD OF GLOBAL PATIENT SOLUTIONS AT GILEAD SCIENCES The worldwide death toll officially attributed to COVID-19 stands at more than 6.5 million. And when researchers include deaths that are likely due to the...